L.B. Foster Reports Second Quarter Operating Results
Aug 09, 2016 11:00 am UTC| Business
PITTSBURGH, Aug. 09, 2016 -- L.B. Foster Company (NASDAQ:FSTR), a leading manufacturer, fabricator, and distributor of products and services for rail, construction, energy and utility markets, today reported its second...
Antares Pharma Reports Second Quarter 2016 Operating and Financial Results
Aug 09, 2016 11:00 am UTC| Business
EWING, N.J., Aug. 09, 2016 -- Antares Pharma, Inc. (NASDAQ:ATRS) today reported operating and financial results for the second quarter ended June 30, 2016. The Company reported revenue of $12.2 million and a net loss...
Nabriva Reports Second Quarter 2016 Financial Results
Aug 09, 2016 11:00 am UTC| Business
LEAP 2 clinical trial initiated in second quarter Reiterates expectation of top-line data from both CABP phase 3 trials in the second half of 2017 VIENNA, Austria and KING OF PRUSSIA, Pa., Aug. 09, 2016 -- Nabriva...
Selecta Biosciences Announces Second Quarter 2016 Financial Results and Provides Corporate Update
Aug 09, 2016 11:00 am UTC| Business
Demonstrated clinical activity in Phase 1 program of SEL-212Advanced two proprietary gene therapy programs based on the same SVP-Rapamycin immunotherapy as SEL-212Successfully completed Initial Public Offering with net...
Plug Power VP to Present at Canaccord Genuity 36th Annual Growth Conference
Aug 09, 2016 11:00 am UTC| Business
LATHAM, N.Y., Aug. 09, 2016 -- Plug Power Inc. (NASDAQ:PLUG), a leader in providing clean, reliable energy solutions, is pleased to announce that Vice President of Business Development and Investor Relations, John...
Scripps Networks Interactive reports second quarter 2016 financial results
Aug 09, 2016 10:58 am UTC| Business
Second quarter 2016 financial highlights: Consolidated operating revenues of $892.8 million, a 21.9% increase;U.S. Networks advertising revenue of $541.0 million, an 8.9% increase;Consolidated operating income of $372.9...
Bellerophon Reports Second Quarter 2016 Financial Results and Provides Business Update
Aug 09, 2016 10:33 am UTC| Business
WARREN, N.J., Aug. 09, 2016 -- Bellerophon Therapeutics,Inc. (Nasdaq:BLPH), a clinical-stage biotherapeutics company, today reported financial results for the second quarter ended June 30, 2016 and provided a business...